Article
Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients.
Breast cancer research and treatment - 1 Jun 2013
Lévy Pierre, Gligorov Joseph, Antoine Martine, Rezai Keyvan, Lévy Eric, Selle Frédéric, Saintigny Pierre, Lokiec François, Avenin Danielle, Beerblock Karine, Lotz Jean-Pierre, Bernaudin Jean-François, Fajac Anne
Abstract excerpt
We have previously reported an association between ABCB1 C3435T polymorphism and docetaxel pharmacokinetics in breast cancer patients. We therefore investigated whether these parameters could account for variations in pathological response. Five ABCB1 polymorphisms including C3435T polymorphism were analyzed in breast cancer patients receiving neoadjuvant chemotherapy with doxorubicin and docetaxel (n = 101)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
